CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-12 | Opaleye Management Inc. 10% owner | Purchase | +3,557 | $6.75 | $24K | 154,900 |
| 2022-02-19 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +50,000 | 273,168 | ||
| 2022-02-19 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −20,605 | $7.87 | $162K | 252,563 |
| 2022-02-19 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Restricted Stock Unit | −50,000 | 0 | ||
| 2022-02-19 | SAHAREK JOHN P. President, ImprimisRx | Option exercise | +50,000 | 80,000 | ||
| 2022-02-19 | SAHAREK JOHN P. President, ImprimisRx | Shares withheld for taxes | −25,923 | $7.87 | $204K | 54,077 |
| 2022-02-19 | SAHAREK JOHN P. President, ImprimisRx | Option exercise · Restricted Stock Unit | −50,000 | 0 | ||
| 2022-01-28 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $6.89 | $34K | 3,140,000 |
| 2022-01-28 | Opaleye Management Inc. 10% owner | Purchase | +1,343 | $6.89 | $9K | 150,000 |
| 2022-01-20 | BAUM MARK L Chief Executive Officer | Option exercise | +125,000 | $2.40 | $300K | 1,478,547 |
| 2022-01-20 | BAUM MARK L Chief Executive Officer | Shares withheld for taxes | −71,406 | $8.33 | $595K | 1,407,141 |
| 2022-01-20 | BAUM MARK L Chief Executive Officer | Option exercise · Stock Option (Right to buy) | −125,000 | 0 | ||
| 2021-09-24 | LINDSTROM RICHARD L MD Director | Sale | −3,900 | $10.04 | $39K | 66,100 |
| 2021-09-16 | LINDSTROM RICHARD L MD Director | Sale | −5,840 | $9.02 | $53K | 70,000 |
| 2021-09-15 | LINDSTROM RICHARD L MD Director | Sale | −14,160 | $9.09 | $129K | 75,840 |
| 2021-08-19 | Opaleye Management Inc. 10% owner | Purchase | +50,000 | $8.45 | $422K | 3,135,000 |
| 2021-08-19 | Opaleye Management Inc. 10% owner | Purchase | +2,500 | $8.45 | $21K | 150,000 |
| 2021-08-18 | Opaleye Management Inc. 10% owner | Purchase | +45,000 | $8.64 | $389K | 3,085,000 |
| 2021-08-18 | Opaleye Management Inc. 10% owner | Purchase | +1,500 | $8.64 | $13K | 147,500 |
| 2021-08-17 | Opaleye Management Inc. 10% owner | Purchase | +25,000 | $8.57 | $214K | 3,040,000 |
Page 8 of 17 · 336 trades